AbbVie, Inc. (ABBV)

198.71 -2.24 (-1.11%) USD  |  NYSE  |  Apr 24, 16:00
197.25 -1.46 (-0.73%) Pre-Market: 07:57
More

AbbVie EPS Diluted (TTM) : 2.361 for Dec. 31, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Amgen, Inc. 14.23
Biogen, Inc. 8.806
Gilead Sciences, Inc. 6.782
Johnson & Johnson 8.649
Regeneron Pharmaceuticals, Inc. 41.56